tradingkey.logo

QuidelOrtho Corp

QDEL
View Detailed Chart
26.970USD
+0.160+0.60%
Close 10/31, 16:00ETQuotes delayed by 15 min
1.83BMarket Cap
LossP/E TTM

QuidelOrtho Corp

26.970
+0.160+0.60%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.60%

5 Days

-9.50%

1 Month

-8.42%

6 Months

-2.95%

Year to Date

-39.46%

1 Year

-30.83%

View Detailed Chart

TradingKey Stock Score of QuidelOrtho Corp

Currency: USD Updated: 2025-10-30

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

QuidelOrtho Corp's Score

Industry at a Glance

Industry Ranking
76 / 210
Overall Ranking
162 / 4621
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 8 analysts
Hold
Current Rating
40.167
Target Price
+43.76%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

QuidelOrtho Corp Highlights

StrengthsRisks
QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.
Fairly Valued
The company’s latest PE is -3.92, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 79.57M shares, decreasing 21.40% quarter-over-quarter.
Held by John Hussman
Star Investor John Hussman holds 42.00K shares of this stock.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

QuidelOrtho Corp Info

QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.
Ticker SymbolQDEL
CompanyQuidelOrtho Corp
CEOMr. Brian J. Blaser
Websitehttps://www.quidelortho.com/
KeyAI